Human FOXP3+ T regulatory cell heterogeneity

FOXP3‐expressing CD4+ T regulatory (Treg) cells are instrumental for the maintenance of self‐tolerance. They are also involved in the prevention of allergy, allograft rejection, foetal rejection during pregnancy and of exaggerated immune response towards commensal pathogens in mucosal tissues. They...

Full description

Saved in:
Bibliographic Details
Published in:Clinical & translational immunology 2018, Vol.7 (1), p.e1005-n/a
Main Authors: Mohr, Audrey, Malhotra, Rajneesh, Mayer, Gaell, Gorochov, Guy, Miyara, Makoto
Format: Article
Language:English
Subjects:
epigenetics
immunotherapy
Life Sciences
regulatory T cells
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:FOXP3‐expressing CD4+ T regulatory (Treg) cells are instrumental for the maintenance of self‐tolerance. They are also involved in the prevention of allergy, allograft rejection, foetal rejection during pregnancy and of exaggerated immune response towards commensal pathogens in mucosal tissues. They can also prevent immune responses against tumors and promote tumor progression. FOXP3‐expressing Treg cells are not a homogenous population. The different subsets of Treg cells can have different functions or roles in the maintenance of immune homeostasis and can therefore be differentially targeted in the management of autoimmune diseases or in cancer. We discuss here how Treg cell subsets can be differentiated phenotypically, functionally and developmentally in humans. Human circulating and tissue infiltrating Treg cells are phenotypically heterogeneous. We discuss here how Treg subsets can be differentiated functionally in the maintenance of immune homeostasis and can be targeted as part of immunotherapy (autoimmune disease or cancer).
ISSN:2050-0068
2050-0068
DOI:10.1002/cti2.1005